David Dolby
Salk Institute for Biological Studies listed David Dolby as TRUSTEE on its 2024 Form 990.
Reported compensation by filing year
Each entry comes from one tax return.
Tax year
Reported total$0
- From filing organization
- $0
- From related organizations
- $0
- Other compensation
- $0
Tax year
Reported total$0
- From filing organization
- $0
- From related organizations
- $0
- Other compensation
- $0
Tax year
Reported total$0
- From filing organization
- $0
- From related organizations
- $0
- Other compensation
- $0
Tax year
Reported total$0
- From filing organization
- $0
- From related organizations
- $0
- Other compensation
- $0
Tax year
Reported total$0
- From filing organization
- $0
- From related organizations
- $0
- Other compensation
- $0
Tax year
Reported total$0
- From filing organization
- $0
- From related organizations
- $0
- Other compensation
- $0
Tax year
Reported total$0
- From filing organization
- $0
- From related organizations
- $0
- Other compensation
- $0
Official bio
David Dolby has served on Salk’s Board of Trustees since 2019. As managing director of Dolby Family Ventures, Dolby oversees a diverse portfolio of more than 40 venture investments, including Internet technology, semiconductors, aerospace, and Alzheimer’s drug discovery. He also serves as a director of Dolby Laboratories and Cogstate Limited and as CFO of the Ray and Dagmar Dolby Family Fund. Beyond his corporate roles, Dolby is an active board member and chair of the impact committee for Tipping Point Community, where he addresses poverty in the Bay Area.